What This Treatment Is

Buprenorphine is a partial opioid agonist — meaning it binds to the same brain receptors as full opioids (like heroin or oxycodone) but activates them only partially. That partial activation is enough to prevent cravings and withdrawal without producing the strong euphoria of full opioid agonism. It’s FDA-approved for opioid use disorder and is the active medication in Suboxone (which pairs buprenorphine with naloxone).

How Buprenorphine Works

Two properties matter. First, the ceiling effect: unlike full opioids, buprenorphine’s effect plateaus at moderate doses. That means less risk of overdose from the medication itself. Second, its high receptor affinity means it stays put — other opioids can’t easily displace it. Practically, this reduces the reinforcement of any relapse attempt: if someone uses another opioid on top of buprenorphine, they don’t get the same effect.

Formulations Available

We prescribe buprenorphine primarily in the sublingual form (Suboxone film or tablet — buprenorphine/naloxone). For patients whose clinical picture calls for it, alternative formulations including monotherapy buprenorphine and extended-release preparations are considered. Formulation choice is a clinical decision made at intake.

Our Care Model: Specialty-Led, Distinct Primary Tracks

Elevated Healing operates separate primary treatment tracks for Mental Health and Substance Use, each led by the appropriate clinical specialty from day one. When both are present, our teams coordinate care across tracks so the full clinical picture is addressed without collapsing treatment into a single generalized program.

This is different from a blended or generalized model. Read more on our Care Model page.

Elevated Healing’s Specialty-Led Approach

Buprenorphine at our Woodland Hills campus is prescribed by board-certified psychiatric providers with substance use expertise. It’s never delivered as an isolated prescription. Every patient on buprenorphine has an active therapy plan, defined follow-up cadence, and — when a mental health condition is also present — coordination with the psychiatric track.

What patients typically experience:

  • Induction: a planned first-dose visit timed to avoid precipitated withdrawal.
  • Titration: dose adjusted in the first 1–2 weeks based on craving control, withdrawal symptoms, and side effects.
  • Maintenance: stable dosing with follow-ups moving from weekly to monthly.
  • Concurrent therapy delivered by licensed clinicians (CBT, DBT, EMDR, ART).
  • Tapering considered only when clinically appropriate and always planned collaboratively.
Evidence base. Peer-reviewed research summarized by the National Institute on Drug Abuse shows buprenorphine significantly reduces overdose mortality and increases treatment retention compared with non-medication approaches for opioid use disorder. Read the NIDA overview →

Access at Our Woodland Hills Campus

Our campus is at 21250 Califa St, Ste 114, Woodland Hills, CA 91367, in the West San Fernando Valley. Access is straightforward:

  • From the 101 (Ventura Freeway) — exit at De Soto Avenue or Winnetka Avenue and drive a short distance north.
  • From the 118 (Ronald Reagan Freeway) — take Winnetka or De Soto south into the West Valley.
  • Nearby communities — Warner Center, Winnetka, West Hills, Canoga Park, Tarzana, and Encino are all a short drive.
  • Telehealth — after your initial in-person assessment, most follow-up psychiatric visits can be done by video for California residents.

Parking and check-in details are provided at intake. If accessibility accommodations are needed, tell our admissions team when you call.

Program Levels That Deliver This Care

This service is delivered inside the level of care that matches your clinical need at intake. Level of care can shift over time as treatment progresses.

Partial Hospitalization (PHP)

Structured day program, five days per week, with psychiatric oversight and integrated therapy.

Learn about PHP

Intensive Outpatient (IOP)

Three-to-five sessions per week that allow work or school to continue.

Learn about IOP

Outpatient (OP)

Weekly therapy plus regular psychiatric visits — well-suited to step-down maintenance.

Learn about OP

Telehealth Follow-Up

Video visits with the psychiatric provider, available across California for eligible patients.

Learn about telehealth

Insurance, Cost, and Getting Started

Most commercial insurance plans cover buprenorphine under mental health and substance use disorder benefits, which are subject to federal parity requirements under the Mental Health Parity and Addiction Equity Act. Parity means insurers cannot impose stricter limits on behavioral health services than they apply to physical health services — a real legal protection worth knowing you have when you call.

The first step is a conversation with our admissions team. This call is free, confidential, and carries no obligation. During it, we:

  • Verify your insurance benefits within one business day.
  • Confirm what’s covered, what your copay or coinsurance will be, and whether prior authorization applies.
  • Start any required prior authorization on your behalf so you’re not stuck on hold with your insurer.
  • Schedule a clinical evaluation — usually within a few business days of your first call, sooner when the situation is time-sensitive.

If insurance doesn’t cover the service or your plan design doesn’t fit, self-pay options can be discussed. There is no charge to have this conversation. Reach us at (747) 888-3000 or use our insurance verification form.

What Progress Looks Like

Recovery through buprenorphine is not a straight line, and durable clinical outcomes rarely happen in weeks. Realistic timelines matter here more than optimistic promises. Most patients notice measurable improvement in the first month of consistent treatment — reduced cravings, more stable mood, better sleep, easier engagement with therapy. Substantive behavioral change typically takes root over three to six months.

Progress is reviewed at every clinical visit. We measure it in specifics: frequency of the target behavior, functional recovery in work and relationships, sleep quality, and — where medications are involved — how well the pharmacology is holding cravings and side effects. When something isn’t working, we adjust. That might mean a dose change, a therapy focus shift, or a step up or down in level of care. The plan follows the patient’s clinical picture, not the other way around.

Setbacks are treated as clinical data, not moral failure. If a relapse or symptom flare happens, the team’s job is to understand what led to it and refine the plan. Patients are not discharged for a relapse. Long-term recovery is often what happens after the acute treatment phase ends, and we plan for that from the first visit — through aftercare planning, coordinated hand-offs, and telehealth follow-up available across California.

Confidentiality and HIPAA Protections

Treatment records at Elevated Healing are protected under the Health Insurance Portability and Accountability Act (HIPAA) and, for substance use records specifically, under 42 CFR Part 2 — a federal regulation providing additional protection for substance use disorder treatment information. That means treatment status and clinical details are not disclosed to family members, employers, or third parties without your written authorization, except in narrowly defined legal circumstances (imminent harm, court order).

Practical protections include HIPAA-compliant scheduling and communication systems, secure insurance verification channels, and billing structured to minimize what appears on statements. Patients with heightened confidentiality concerns can request specific accommodations at intake — arrival timing, check-in flow, telehealth-first scheduling — and our admissions team will confirm what’s available.

Frequently Asked Questions

What's the difference between buprenorphine and Suboxone?
Suboxone is a brand-name product that combines buprenorphine with naloxone. The active medication for treating opioid use disorder is buprenorphine. Naloxone is included as a misuse deterrent (it activates if someone tries to inject the medication). Most of our patients receive the combination product; monotherapy buprenorphine is used in specific clinical situations like pregnancy.
Is buprenorphine addictive?
Buprenorphine causes physical dependence — meaning if you stop it abruptly, you’ll experience withdrawal. That’s different from addiction, which involves compulsive use despite harm. When taken as prescribed for opioid use disorder, buprenorphine is a treatment for addiction, not a substitute addiction.
Can I take buprenorphine while pregnant?
Buprenorphine is one of the first-line MAT options considered during pregnancy, per obstetric and addiction medicine guidance. Formulation and dose require careful review with an OB and psychiatric provider familiar with perinatal MAT. Our team coordinates with your obstetric care.
How is buprenorphine dose determined?
Starting dose is guided by clinical protocol; ongoing dose is titrated based on your response — craving control, withdrawal symptoms, side effects. Typical maintenance doses fall between 8 mg and 24 mg daily. Some patients need less; some need more. This is a clinical decision reviewed at each visit.
What if buprenorphine doesn't feel like it's working?
Tell your provider directly. Dose can be adjusted, timing can be reviewed, and other medication options (like extended-release naltrexone or a referral for methadone) can be considered. Buprenorphine isn’t the right fit for every patient, and switching medications when clinically warranted isn’t a failure.
Does insurance cover buprenorphine treatment?
Most commercial insurance plans cover the medication and the associated psychiatric visits and therapy. Our admissions team verifies benefits within one business day. Reach us at (747) 888-3000.

If You’re in Crisis

If you or someone you love is in immediate crisis, help is available 24/7. You are not alone.

Trusted External Resources

Independent, evidence-based sources on the topics covered on this page:

SAMHSA — Buprenorphine →

Federal public health agency’s overview of buprenorphine for opioid use disorder.

FDA — Information About MOUD →

FDA drug information on buprenorphine and other OUD medications.

National Institute on Drug Abuse →

NIH institute publishing research on addiction neuroscience and treatment efficacy.

American Psychiatric Association →

APA’s public-facing guidance on substance use disorders and treatment options.

CDC Overdose Prevention →

CDC data and prevention resources for opioid overdose.

Ready to Talk About Buprenorphine?

Our admissions team can walk you through what treatment looks like, verify insurance benefits, and answer questions. Conversations are confidential.

Call us confidentially at (747) 888-3000 — or request a consultation online.

Schedule Your Consultation
Vital Voice Online

Schedule a Consultation

Fill out the form below and we'll get back to you within 24 hours.

Request Sent!

We've received your request and will be in touch within 24 hours.

Something went wrong